Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.47 |
| ▸ | CTSS | P25774 | 13/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2105235 | 1.00 | MMP2 (0.47) | MMP2CTSSCYP3A4CYP2C9ADAM17 | |
| SCHEMBL695501 | 0.89 | CTSS (0.47) | MMP2CTSSCYP3A4CYP2C9ADAM17 | |
| SCHEMBL2105712 | 0.89 | CTSS (0.47) | MMP2CTSSCYP3A4CYP2C9ADAM17 | |
| SCHEMBL695606 | 0.86 | CTSS (0.54) | MMP2CTSS | |
| SCHEMBL696507 | 0.86 | CTSS (0.54) | MMP2CTSS | |
| SCHEMBL2104430 | 0.86 | CTSS (0.54) | MMP2CTSS | |
| SCHEMBL697112 | 0.83 | CTSS (0.45) | CTSS | |
| SCHEMBL697028 | 0.83 | CTSS (0.45) | CTSS | |
| SCHEMBL697027 | 0.83 | CTSS (0.45) | CTSS | |
| SCHEMBL2105273 | 0.81 | MMP2 (0.44) | MMP2ADAM17MEN1KMT2AANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2421826-A1 | PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010121918-A1 | PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-10-28 | — | — | WO | disclosed |